Skip to search.
 TSX Down 0.94% TSX Ventures Down 3.46%

Abbott Laboratories (ABT)

-NYSE
43.17 Down 0.73(1.66%) Aug 24, 4:00PM EDT
|After Hours : 43.25 Up 0.08 (0.19%) Aug 24, 5:33PM EDT
Prev Close:43.90
Open:43.96
Bid:43.13 x 100
Ask:43.25 x 300
1y Target Est:48.00
Beta:1.56896
Earnings Date:Oct 19 - Oct 24 (Est.)
Day's Range:43.07 - 44.10
52wk Range:36.00 - 46.63
Volume:7,578,510
Avg Vol (3m):9,956,090
Market Cap:63.46B
P/E (ttm):28.50
EPS (ttm):1.52
Div & Yield:1.04 (2.35%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTDown 1.66%63.46B

Key Statistics

Forward P/E (1 yr):17.55
P/S (ttm):3.14
Ex-Dividend Date:13-Jul-16

Analysts

Annual EPS Est (Dec-16) :2.20
Quarterly EPS Est (Sep-16) :0.58
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. The company’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome o... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback